Skip to content

Normal Values for Myocardial Left Atrial Strain

Normal Values for Myocardial Left Atrial Strain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03874624
Enrollment
43
Registered
2019-03-14
Start date
2019-02-22
Completion date
2019-05-31
Last updated
2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Function

Brief summary

Transversal retrospective and unicentric study. The investigators sought to determine the normal values for two-dimensional myocardial left atrial strain for the cardiology ultrasound system available in their centre (Philips EPIQ ultrasound machine and 10.8.5 QLAB cardiac analysis software). Studies performed in their department which meet the criteria for an adequate strain analysis will be retrospectively reviewed.

Interventions

DIAGNOSTIC_TESTtwo-dimensional speckle tracking

Analysis of myocardial left atrial strain using two-dimensional speckle tracking echocardiography.

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* No history of cardiopathy / pneumopathy. * No history of hypertension or mellitus diabetes.

Exclusion criteria

* Pregnancy. * Athletes. * Body mass index \< 16 or =\> 30 kg/m2. * Previous treatment with cardiotoxic chemotherapy. * Dilated left ventricle (telediastolic diameter index \> 30 mm/m2). * Interventricular septal thickness =\> 12 mm. * Dilated left atria (volume =\> 31 ml/m2). * Systolic pulmonary pressure =\> 35 mmHg. * Moderate or severe valvulopathy. * Incomplete or suboptimal left atrial visualization. * Frame rate \< 50 fps.

Design outcomes

Primary

MeasureTime frameDescription
Global peak reservoir strain.Through study completion, an average of 4 months.Percentage of peak reservoir strain for 4-, 2- and 3-chambers will be combined to report percentage of global peak reservoir strain.
Global pump strain.Through study completion, an average of 4 months.Percentage of pump reservoir strain for 4-, 2- and 3-chambers will be combined to report percentage of global pump strain.
Global conductance strain.Through study completion, an average of 4 months.Measured as the difference between global reservoir strain and gobal pump strain.
Global reservoir strain rate.Through study completion, an average of 4 months.Reservoir strain rate for 4-, 2- and 3-chambers will be combined to report global reservoir strain rate.
Global conductance strain rate.Through study completion, an average of 4 months.Conductance strain rate for 4-, 2- and 3-chambers will be combined to report global conductance strain rate.
Global pump strain rate.Through study completion, an average of 4 months.Pump strain rate for 4-, 2- and 3-chambers will be combined to report global pump strain rate.

Secondary

MeasureTime frameDescription
Left ventricular telediastolic volumeThrough study completion, an average of 4 months.Measured by Simpson's method
Left ventricular dimensionsThrough study completion, an average of 4 months.Assessed by the following parameters: telediastolic diameter, interventricular septal thickness, posterior wall thickness (in mm)
Age in yearsThrough study completion, an average of 4 months.
E/e' ratioThrough study completion, an average of 4 months.Tissue doppler derived parameter.
E/A ratioThrough study completion, an average of 4 months.Transmitral flow profile.
SexThrough study completion, an average of 4 months.male or female
Weight in kilogramsThrough study completion, an average of 4 months.
Height in metersThrough study completion, an average of 4 months.
Left atrial volumeThrough study completion, an average of 4 months.Measured by biplanar volumetric method
Left ventricular ejection fractionThrough study completion, an average of 4 months.Measured by biplanar Simpson's method

Countries

Spain

Contacts

Primary ContactLidia Bos Real
lbos@santpau.cat0034935537058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026